SCHEMBL4319792

SCHEMBL4319792

Cc1ccsc1C(=O)Nc1ccc(OCCN2CCOCC2)cc1/C=C/c1n[nH]c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 4/20 0.51
▸ AURKB Q96GD4 4/20 0.51
▸ PDGFRB P09619 2/20 0.41
▸ PDGFRA P16234 1/20 0.41
▸ MAPK14 Q16539 3/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ KDR P35968 4/20 0.39
▸ FLT3 P36888 4/20 0.39
▸ KCNA5 P22460 2/20 0.39
▸ FGFR1 P11362 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ MAPK13 O15264 1/20 0.38
▸ MAPK12 P53778 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ BCL3 P20749 1/20 0.38
▸ JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4319796 1.00 AURKA (0.51) AURKAAURKBPDGFRBPDGFRAMAPK14
SCHEMBL4308978 0.94 AURKB (0.56) AURKAAURKBPDGFRBPDGFRAMAPK14
SCHEMBL4308984 0.94 AURKB (0.56) AURKAAURKBPDGFRBPDGFRAMAPK14
SCHEMBL4309030 0.89 AURKA (0.51) AURKAAURKBMAPK14HDAC1KDR
SCHEMBL4309036 0.89 AURKA (0.51) AURKAAURKBMAPK14HDAC1KDR
SCHEMBL4313754 0.86 AURKA (0.49) AURKAAURKBMAPK14MAPK13MAPK12
SCHEMBL4313758 0.86 AURKA (0.49) AURKAAURKBMAPK14MAPK13MAPK12
SCHEMBL4324776 0.85 AURKA (0.51) AURKAAURKBPDGFRAMAPK14HDAC1
SCHEMBL4324783 0.85 AURKA (0.51) AURKAAURKBPDGFRAMAPK14HDAC1
SCHEMBL4310312 0.85 PDGFRB (0.43) AURKAAURKBPDGFRBPDGFRAMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 AURKA 3687/4885AURKB 3438/4885PDGFRB 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback